[go: up one dir, main page]

IL130303A0 - A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use - Google Patents

A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Info

Publication number
IL130303A0
IL130303A0 IL13030399A IL13030399A IL130303A0 IL 130303 A0 IL130303 A0 IL 130303A0 IL 13030399 A IL13030399 A IL 13030399A IL 13030399 A IL13030399 A IL 13030399A IL 130303 A0 IL130303 A0 IL 130303A0
Authority
IL
Israel
Prior art keywords
probiotic
human
bacterial strain
plant extracts
veterinary use
Prior art date
Application number
IL13030399A
Other languages
English (en)
Original Assignee
M G Novobiotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M G Novobiotech Ltd filed Critical M G Novobiotech Ltd
Priority to IL13030399A priority Critical patent/IL130303A0/xx
Priority to EP00931522A priority patent/EP1185618B1/fr
Priority to BR0012104-5A priority patent/BR0012104A/pt
Priority to PT00931522T priority patent/PT1185618E/pt
Priority to HK02104624.4A priority patent/HK1043154B/en
Priority to AU49470/00A priority patent/AU778789B2/en
Priority to AT00931522T priority patent/ATE349510T1/de
Priority to KR1020017015533A priority patent/KR100694820B1/ko
Priority to PCT/IL2000/000318 priority patent/WO2000075284A1/fr
Priority to NZ527587A priority patent/NZ527587A/en
Publication of IL130303A0 publication Critical patent/IL130303A0/xx
Priority to JP2001502550A priority patent/JP4623896B2/ja
Priority to DE60032599T priority patent/DE60032599T2/de
Priority to PL00352703A priority patent/PL352703A1/xx
Priority to MXPA01012460A priority patent/MXPA01012460A/es
Priority to CA2375599A priority patent/CA2375599C/fr
Priority to ES00931522T priority patent/ES2280215T3/es
Priority to NZ515830A priority patent/NZ515830A/en
Priority to US09/725,846 priority patent/US6500423B2/en
Priority to US09/986,857 priority patent/US6503505B2/en
Priority to US09/986,851 priority patent/US6511661B2/en
Priority to US09/986,861 priority patent/US6569424B2/en
Priority to US09/986,854 priority patent/US6534053B2/en
Priority to US09/986,852 priority patent/US6524576B2/en
Priority to US09/986,858 priority patent/US6544509B2/en
Priority to US09/986,855 priority patent/US6534054B2/en
Priority to US09/986,856 priority patent/US6544508B2/en
Priority to US09/986,853 priority patent/US6500424B2/en
Priority to US09/986,859 priority patent/US6500467B2/en
Priority to US09/986,862 priority patent/US6514494B2/en
Priority to US09/986,850 priority patent/US6524575B2/en
Priority to US09/986,860 priority patent/US6544510B2/en
Priority to US10/432,346 priority patent/US7504251B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84—Flavour masking or reducing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
IL13030399A 1999-06-03 1999-06-03 A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use IL130303A0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
IL13030399A IL130303A0 (en) 1999-06-03 1999-06-03 A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
ES00931522T ES2280215T3 (es) 1999-06-03 2000-06-01 Una cepa bacteriana, extractos vegetales procesados y composiciones probioticas para uso humano y veterinario.
CA2375599A CA2375599C (fr) 1999-06-03 2000-06-01 Compositions probiotiques comprenant e. coli et des fractions volatiles d'extraits de plantes
PT00931522T PT1185618E (pt) 1999-06-03 2000-06-01 Estirpe bacteriana, extractos de plantas processados e composições probiotica para utilização humana e veterinária.
HK02104624.4A HK1043154B (en) 1999-06-03 2000-06-01 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
AU49470/00A AU778789B2 (en) 1999-06-03 2000-06-01 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
AT00931522T ATE349510T1 (de) 1999-06-03 2000-06-01 Bakterienstamm, verarbeitete pflanzenextrakte und probiotische zubereitungen für die menschliche und tierärtzliche verwendung
KR1020017015533A KR100694820B1 (ko) 1999-06-03 2000-06-01 박테리아 균주 및 인간 및 수의학적 사용을 위한 생균활성 조성물
PCT/IL2000/000318 WO2000075284A1 (fr) 1999-06-03 2000-06-01 Souche bacterienne, extraits de plantes traites et composition probiotique a usage medical et veterinaire
NZ515830A NZ515830A (en) 1999-06-03 2000-06-01 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
BR0012104-5A BR0012104A (pt) 1999-06-03 2000-06-01 Cepa escherichia coli bu-230-98, formulação que compreende pelo menos uma fração volátil (fv) de um extrato de planta, aditivo alimentar veterinário, composição probiótica, processo de preparação de uma fração volátil de um extrato de planta, uso de fração volátil (fv) de um extrato de planta, formulação com fração volátil, processo de preparação de um aditivo alimentar, uso de uma composição que compreende pelo menos uma fração volátil de um extrato de planta e processo para a preparação de uma composição probiótica que compreende pelo menos a fração volátil de um extrato de planta
JP2001502550A JP4623896B2 (ja) 1999-06-03 2000-06-01 ヒトおよび動物に使用される細菌株、加工された植物抽出物およびプロバイオティック組成物
DE60032599T DE60032599T2 (de) 1999-06-03 2000-06-01 Bakterienstamm, verarbeitete pflanzenextrakte und probiotische zubereitungen für die menschliche und tierärtzliche verwendung
PL00352703A PL352703A1 (en) 1999-06-03 2000-06-01 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
MXPA01012460A MXPA01012460A (es) 1999-06-03 2000-06-01 Una cepa bacteriana, extractos de planta procesadas y composiciones probisticas para uso humano y veterinario.
EP00931522A EP1185618B1 (fr) 1999-06-03 2000-06-01 Souche bacterienne, extraits de plantes traites et composition probiotique a usage medical et veterinaire
NZ527587A NZ527587A (en) 1999-06-03 2000-06-01 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
US09/725,846 US6500423B2 (en) 1999-06-03 2000-11-30 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,857 US6503505B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,860 US6544510B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,856 US6544508B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,861 US6569424B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processes plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,854 US6534053B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,852 US6524576B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,858 US6544509B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,855 US6534054B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,851 US6511661B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,853 US6500424B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,859 US6500467B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,862 US6514494B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compostions containing same, processes for their preparation and their therapeutic and industrial applications
US09/986,850 US6524575B2 (en) 1999-06-03 2001-11-13 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US10/432,346 US7504251B2 (en) 1999-06-03 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13030399A IL130303A0 (en) 1999-06-03 1999-06-03 A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Publications (1)

Publication Number Publication Date
IL130303A0 true IL130303A0 (en) 2000-06-01

Family

ID=11072878

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13030399A IL130303A0 (en) 1999-06-03 1999-06-03 A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Country Status (17)

Country Link
US (14) US6500423B2 (fr)
EP (1) EP1185618B1 (fr)
JP (1) JP4623896B2 (fr)
KR (1) KR100694820B1 (fr)
AT (1) ATE349510T1 (fr)
AU (1) AU778789B2 (fr)
BR (1) BR0012104A (fr)
CA (1) CA2375599C (fr)
DE (1) DE60032599T2 (fr)
ES (1) ES2280215T3 (fr)
HK (1) HK1043154B (fr)
IL (1) IL130303A0 (fr)
MX (1) MXPA01012460A (fr)
NZ (2) NZ515830A (fr)
PL (1) PL352703A1 (fr)
PT (1) PT1185618E (fr)
WO (1) WO2000075284A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504251B2 (en) 1999-06-03 2009-03-17 Biobalance Llc Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
NL1015980C2 (nl) * 2000-08-22 2002-02-25 Pk Holdline B V Voedingssupplement dat een knoflookproduct bevat.
SE518097C2 (sv) * 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
KR20030082549A (ko) * 2000-11-30 2003-10-22 더 바이오 밸런스 코포레이션 박테리아 균주, 처리된 식물 추출물, 이를 함유하는조성물, 이의 제조방법 및 치료적 용도 및 산업적 용도
US20030185811A1 (en) * 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
US7080139B1 (en) 2001-04-24 2006-07-18 Fatbubble, Inc Method and apparatus for selectively sharing and passively tracking communication device experiences
FR2827774B1 (fr) * 2001-07-30 2005-06-24 Dolisos Lab Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US6953574B2 (en) 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
FR2854769B1 (fr) * 2003-05-16 2009-07-17 Alfalis Utilisation d'un extrait soluble de luzerne pour freiner la prise de poids chez les mammiferes
US20040234579A1 (en) * 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
EP1654348A4 (fr) * 2003-08-14 2008-02-13 Bio Balance Corp Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
BRPI0413460A (pt) * 2003-08-15 2006-10-17 Grain Processing Corp método para dissociação de células
JP2007518693A (ja) * 2003-08-18 2007-07-12 ザ バイオ バランス コーポレイション 安定な液体プロバイオティクス組成物、その調製および適用
EP1667649A4 (fr) * 2003-10-02 2011-07-06 Bio Balance Corp Composition biotherapeutique sechee, ses utilisations et son dispositif et ses procedes d'administration
US20070009490A1 (en) * 2003-10-02 2007-01-11 Conte Anthony E Dried biotherapeutic composition, uses, and device and methods for administration thereof
WO2005060498A2 (fr) * 2003-12-16 2005-07-07 University Of Georgia Research Foundation, Inc. Composition et procede d'inhibition de la colonisation par salmonella et campylobacter chez des volailles
HUE024565T2 (hu) 2004-02-03 2016-02-29 Prevtec Microbia Inc Élõ baktériumok alkalmazása növekedésserkentésre állatokban
US20050186188A1 (en) * 2004-02-19 2005-08-25 Peilin Guo Compositions containing probiotics and polysaccharides and methods of use
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
CN101128187A (zh) * 2005-02-09 2008-02-20 达沃尔泰拉公司 活性剂的结肠递送
DE102005016147B4 (de) * 2005-04-07 2007-11-08 Bury Sp.Z.O.O Fernbedienung
JP5009521B2 (ja) * 2005-10-24 2012-08-22 国立大学法人東京海洋大学 動物の飼育方法
WO2007136553A2 (fr) * 2006-05-18 2007-11-29 Biobalance Llc Souches bactériennes, compositions les contenant et utilisation probiotique de ces souches
US20080107699A1 (en) * 2006-10-25 2008-05-08 Mark Spigelman Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor
US8273376B2 (en) * 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
US20080124279A1 (en) * 2006-11-17 2008-05-29 Antoine Andremont Colonic delivery using Zn/pectin beads with a Eudragit coating
US20100009028A1 (en) * 2008-07-09 2010-01-14 Grain Processing Corporation Method for Dissociation of Cells
US9603876B2 (en) 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
US8951512B2 (en) 2010-05-04 2015-02-10 New York University Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
US9386793B2 (en) 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
PT2875121T (pt) * 2012-07-20 2018-03-14 Prevtec Microbia Inc Estirpe de e. coli f18 não patogénica e utilização da mesma
US10383921B2 (en) 2013-08-13 2019-08-20 President And Fellows Of Harvard College Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis
WO2016109509A1 (fr) * 2014-12-31 2016-07-07 University of Central Oklahoma Formulation et procédé pour la production de produits alimentaires et à boire probiotiques fermentés
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
US10596206B1 (en) 2017-03-14 2020-03-24 Cornell University Probiotic compositions and methods of use
WO2019118984A2 (fr) 2017-12-15 2019-06-20 Solarea Bio, Inc. Compositions microbiennes et méthodes de traitement du diabète de type 2, de l'obésité et du syndrome métabolique
EP3846830A4 (fr) 2018-09-05 2022-07-06 Solarea Bio, Inc. Méthodes et compositions pour le traitement de maladie musculo-squelettiques
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CN113023905A (zh) * 2021-03-31 2021-06-25 北京局气网络技术有限公司 一种调节淡水水质的植物发酵提取物及其制备方法
CN114292801A (zh) * 2021-11-22 2022-04-08 龚志术 一种益生菌菌株的驯化方法、益生菌菌株、扶微乳及其制备方法
AU2022391767A1 (en) 2021-11-22 2024-07-04 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
CN115011739B (zh) * 2022-08-03 2022-11-01 南京邦康生物技术有限公司 一种益生菌的生产控制方法与系统
WO2025069015A1 (fr) * 2023-09-29 2025-04-03 Badan Riset Dan Inovasi Nasional (Brin) Composition d'additifs alimentaires pour volaille à base de bactériophages

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908028A (en) * 1973-04-19 1975-09-23 Procter & Gamble Soft drink composition containing paramethoxycinnamaldehyde as a flavoring agent and sweetner
GB1501098A (en) * 1974-06-11 1978-02-15 Brewing Patents Ltd Preparation of hop oil
CA1047436A (fr) * 1974-06-11 1979-01-30 Brewing Patents Limited Preparation de l'huile de houblon
JPS5618565A (en) * 1979-07-20 1981-02-21 Tsuji Seiyu Kk Preparation of mustard
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5019506A (en) 1986-05-21 1991-05-28 University College, Cork Plasmid and uses thereof
US4986985A (en) * 1987-11-02 1991-01-22 Bar Ilan University Method of treating skin virus infections
CH675685A5 (fr) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5082489A (en) * 1990-02-06 1992-01-21 The Royal Institution For The Advancement Of Learning (Mcgill University) Composition for biocontrol of wild buckwheat
US5017397A (en) * 1990-04-25 1991-05-21 Uy Nguyen Process for extracting antioxidants from Labiatae herbs
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5486367A (en) * 1992-10-13 1996-01-23 Kansas State University Research Foundation Enzymatic method for accelerating fermentation of comestible products
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
JPH0746963A (ja) * 1993-08-06 1995-02-21 Nippon Terupen Kagaku Kk 家畜用飼料
US5691185A (en) 1993-10-08 1997-11-25 Chr. Hansen A/S Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria
FR2717492B1 (fr) * 1994-03-15 1996-04-12 Commissariat Energie Atomique Procédé et installation d'extraction d'une huile essentielle à partir de végétaux.
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
AU714310B2 (en) * 1995-05-12 1999-12-23 Japan Pharmaceutical Development Co., Ltd Plant extract
CN1124855C (zh) * 1995-05-26 2003-10-22 罗帕法姆公司 牛至油制备治疗微生物引起动物胃肠道疾病的药物的用途
US5679364A (en) * 1995-06-07 1997-10-21 Lee County Mosquito Control District Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments
EP0750042A1 (fr) 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
SE9502588L (sv) 1995-07-13 1997-01-14 Moelnlycke Ab Hämning av tillväxten av bakterier i samband med absorberande alster med hjälp av tillsats av andra bakterier
GB2303799B (en) * 1995-07-29 1999-03-10 Siemens Plc Improvements in or relating to aqueous sample testing apparatus
JP3336366B2 (ja) * 1996-02-26 2002-10-21 雅子 佐藤 抗菌性成分、それを混入した材料及び溶液
US5888395A (en) * 1996-08-30 1999-03-30 The Regents Of The University Of California Method for enhanced longevity of in situ microbial filter used for bioremediation
EP0964693B1 (fr) 1996-09-05 2010-04-14 The Governors Of The University Of Alberta Nouvelles bacteriocines, nouveau systeme de transport et de vecteur et procede d'utilisation associe
US5773075A (en) * 1996-12-13 1998-06-30 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of Capsicum solids
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
US5891501A (en) * 1997-11-25 1999-04-06 Mckellip; Lewis L. Method for extraction of essential oils from plant material
US20010049132A1 (en) 2000-03-21 2001-12-06 Borge Kringelum Method for supply of starter cultures having a consistent quality

Also Published As

Publication number Publication date
US20020051775A1 (en) 2002-05-02
PL352703A1 (en) 2003-09-08
US6524575B2 (en) 2003-02-25
US6544508B2 (en) 2003-04-08
US20020054868A1 (en) 2002-05-09
US6524576B2 (en) 2003-02-25
NZ527587A (en) 2005-01-28
AU778789B2 (en) 2004-12-23
US20010001711A1 (en) 2001-05-24
NZ515830A (en) 2003-11-28
US20020051774A1 (en) 2002-05-02
US6503505B2 (en) 2003-01-07
US6569424B2 (en) 2003-05-27
US20020048568A1 (en) 2002-04-25
KR100694820B1 (ko) 2007-03-14
PT1185618E (pt) 2007-04-30
CA2375599C (fr) 2010-10-12
US20020048567A1 (en) 2002-04-25
US6500424B2 (en) 2002-12-31
DE60032599T2 (de) 2007-10-04
US6544510B2 (en) 2003-04-08
DE60032599D1 (de) 2007-02-08
US6511661B2 (en) 2003-01-28
US20020051772A1 (en) 2002-05-02
HK1043154A1 (en) 2002-09-06
AU4947000A (en) 2000-12-28
ATE349510T1 (de) 2007-01-15
US6534053B2 (en) 2003-03-18
US20020051773A1 (en) 2002-05-02
US20020054866A1 (en) 2002-05-09
US20020051776A1 (en) 2002-05-02
US20020054867A1 (en) 2002-05-09
US20020048570A1 (en) 2002-04-25
US6534054B2 (en) 2003-03-18
US20020071835A1 (en) 2002-06-13
ES2280215T3 (es) 2007-09-16
US20020048569A1 (en) 2002-04-25
JP2003501080A (ja) 2003-01-14
US6514494B2 (en) 2003-02-04
WO2000075284A1 (fr) 2000-12-14
JP4623896B2 (ja) 2011-02-02
CA2375599A1 (fr) 2000-12-14
BR0012104A (pt) 2002-03-12
KR20020019059A (ko) 2002-03-09
MXPA01012460A (es) 2005-04-19
EP1185618A1 (fr) 2002-03-13
HK1043154B (en) 2007-08-03
US6544509B2 (en) 2003-04-08
US6500467B2 (en) 2002-12-31
EP1185618B1 (fr) 2006-12-27
US6500423B2 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
IL130303A0 (en) A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
PL366363A1 (en) Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
AU3697197A (en) Use,in a composition, of an extract of at least one labiate
PT746327E (pt) Nitrito acidificado como um agente antimicrobiano
WO2002041837A3 (fr) Traitement de mucosite
PL348973A1 (en) Oral administration of lactobacillus for the treatment and prevention of urogenital infection
MX9710479A (es) Extracto de iridaceas y composiciones que la contienen.
WO2001087083A3 (fr) Fractionnement et traitement d'aliments a base de graines oleagineuses
IS2667B (is) Lyfjablanda sem inniheldur andrógen
GEP20043180B (en) Polymorphous Crystal Forms of Celecoxib, Methods for Their Production and Pharmaceutical Composition Comprising the Same for Treatment or Prevention of Diseases Caused by Cyclooxygenase-2
MY133372A (en) Foods comprising a gel composition and process of manufacture
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
NZ336337A (en) Antimicrobial proteins derived from Macadamia integrifolia, cotton and cocoa seeds useful in the treatment of microbial infection in plants and humans
GEP20053721B (en) Solid Composition Containing Bacillus- Type Non-Pathogenic Bacterial Spores
MX2025000629A (es) Cepas de lactobacillus salivarius y usos de las mismas
MD960242A (en) Microorganisms for biological control of plants diseases
MX2022015855A (es) Gel hidroalcoholico y un metodo de fabricacion del gel.
IL141325A0 (en) Tan-1057 derivatives
WO2003009859A1 (fr) Immunotherapie pour humains
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
FI944557A0 (fi) Mikro-organismi kasvitautien biologiseen torjuntaan
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
HK1058882A (en) Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
Gautam et al. 15 Role of the Oral Microbiome

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees